Modernizing a Cancer Medications Platform: Stories, Diversity, and Lessons Learned
Cancer is the second leading cause of death in the United states and the American Cancer Society estimates that about one-third of all people in the United States will develop cancer during their lifetimes. There have been a number of breakthroughs in medications for the treatment of cancer and there are more options than ever before. The formulary of an oncology electronic medical record system is the backbone of making these medications available to important parts of the system such as regimens (drugs given using several different medications which may be given at the same time, or one after another for a specific period of time). We’ve spent a good amount of time and resources refactoring the formulary of Flatiron’s electronic medical records application and have learned a lot and would like to share this with you.
We’ll tell you stories about a brief history of cancer, the evolution of oncology medications, our story of rebuilding a formulary, the engineering challenges we faced and how diversity of thought can help improve the direction of projects. We’ll explain why we believe these stories are important, the lessons we learned from them, and the major diversity gaps that currently exist throughout the world of cancer medication.
Presenter: Ina Ochoche, Staff Software Engineer, Flatiron Health